Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
Canafax
D M
DM
College of Pharmacy, Department of Pharmacy Practice, University of Minnesota, Minneapolis.
Savik
S K
SK
Draxler
C A
CA
Le
C T
CT
Ascher
N L
NL
Payne
W D
WD
Sutherland
D E
DE
Migliori
R J
RJ
Simmons
R L
RL
Najarian
J S
JS
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D011379:Prognosis; D012044:Regression Analysis; D012307:Risk Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone